$AFCG

TANNENBAUM LEONARD M purchased $88K of AFCG

TANNENBAUM LEONARD M purchased 25,228 shares of Advanced Flower Capital Inc. (AFCG) at an average of $3.50 ($3.49–$3.52) across 2 trades over 2026-09-24 to 2026-09-25.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Sep 28, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 2:46 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AFCG
Neutral
high confidence
Mentioned
$AFCG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The insider buy adds a modest data point to the company's ownership structure but lacks material impact.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 4/10Novelty 4/10Timing: post‑filing today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$AFCGNeutralHigh confidence
Context

Director Leonard Tannenbaum purchased 25,228 shares for $88K, increasing his stake to over 7 million shares.

Expected impact

minimal pressure as market may view purchase as low‑impact.

Evidence & confidence

The transaction is a routine Form 4 filing with a modest dollar amount; unlikely to move the stock materially.

Market effects

none

none

none

Counterpoint

The purchase could be a signal of undervaluation, but size is too small to act on.

Key entities

  • Advanced Flower Capital Inc.

    Issuer of the Form 4 filing.

  • Leonard M. Tannenbaum

    Director and 10% owner of AFCG.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): AFC Announces Financial Results for the Second Quarter 2026

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.